Get the Stockscreener App
11.24
24.97%
-3.74
After Hours:
11.55
0.31
+2.76%
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Latest News
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 12.6%Time to Sell? - MarketBeat
Tonix Pharma Announces Promising Phase 1 Trial Results - TipRanks
Tonix reports positive results in TNX-1500 phase 1 trial - Investing.com
Tonix Pharmaceuticals Announces Positive Topline Results - GlobeNewswire
Breakthrough in Transplant Medicine: Novel Anti-CD40L Antibody Achieves Key Clinical Milestones - StockTitan
Tonix Pharmaceuticals announces reverse stock split - MSN
Tonix Pharmaceuticals appoints new CTO amid drug development - MSN
Tonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated by Analysts at StockNews.com - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.7%Time to Sell? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap DownWhat's Next? - MarketBeat
TNXPTonix Pharmaceuticals Holding Corp. Latest Stock News & Market Updates - StockTitan
Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference - GlobeNewswire
Tonix's FDA Fast-Tracked Fibromyalgia Treatment Takes Center Stage at Major Investor Conference - StockTitan
Tonix Pharmaceuticals appoints new CTO amid drug development By Investing.com - Investing.com South Africa
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer - citybiz
Tonix Pharma Promotes Fogarty to Chief Technology Officer - TipRanks
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Craters on Stock Split before FDA Call - TipRanks
Tonix's Leadership Shakeup: New CTO to Spearhead $34M Defense Contract & Critical FDA Review - StockTitan
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 11.5% HigherWhat's Next? - MarketBeat
Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Benzinga
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 7.7%Should You Sell? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 6.7%Should You Buy? - MarketBeat
Tonix Pharmaceuticals announces reverse stock split By Investing.com - Investing.com Canada
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split - GlobeNewswire
Crude Oil Moves Higher; Owens & Minor Shares Plummet - Benzinga
Dow Falls 150 Points; ISM Manufacturing PMI Rises In January - Benzinga
S&P 500 Down Over 1%; Tyson Foods Posts Upbeat Results - Benzinga
Tonix Pharma Strategic Moves: Loan Termination and Stock Split - TipRanks
Major Restructuring: Tonix's 1:100 Reverse Split Precedes Critical FDA Decision on Fibromyalgia Drug - StockTitan
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 7.7%Time to Sell? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 21.8% HigherHere's What Happened - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 11.5%What's Next? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 6.7%Should You Buy? - MarketBeat
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Large Growth in Short Interest - MarketBeat
Tonix Pharmaceuticals Holding Corp at Biotechnology Industry Organization (BIO) CEO & Investor Conference (Virtual)Virtual Presentation Transcript - GuruFocus.com
Tonix Pharmaceuticals announces acquisition of Healion Bio antiviral portfolio Transcript - GuruFocus.com
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 21.8%What's Next? - MarketBeat
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Significant Increase in Short Interest - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 11.5%What's Next? - MarketBeat
The Future of Biotech? Meet the Game-Changer in Nasdaq: TNXP - Be3
Is Tonix Pharmaceuticals the Next Biotech Breakout? - MSN
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):